Company intelligence / Profile preview

Beijing Dabeinong Biotechnology

Beijing, Beijing, Chinaen.dbnbc.com ↗
Ownership
Private
Employees
~18465
Development stage
Commercial
01

Overview

Beijing Dabeinong Biotechnology develops genetically modified seeds—mainly insect-resistant/herbicide-tolerant soybeans and corn—and advanced crop breeding solutions. Its transgenic soybean event DBN8002 has been approved for cultivation in Argentina. Several GM corn/soybean events have received biosafety certificates from Chinese authorities. The company also collaborates internationally on trait discovery to improve fertilizer uptake/drought tolerance.

Therapeutic areas
OtherInfectious Diseases
Modalities
Genetically modified crops (GMOs)Transgenic technologySeed breeding technologyAnimal vaccine developmentSmall molecule (for animal health products)Protein (for some crop traits)
Industry
Agriculture & AgTech
02

Drug pipeline

4 assets

FARMAX Baokang

Commercial
Indications
Insect resistance, Herbicide tolerance

3 more assets in the full pipeline.

Request access →
03

Partnerships

Evogene Ltd. (collaboration on improved rice traits)Fuhua Group (strategic partnership announced Feb.2025)over 200 domestic/international seed companies/breeding institutions

Beyond the preview

Go deeper on Beijing Dabeinong Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Dabeinong Biotechnology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call